| Nearly 20% of adult women in the U.S. report moderate to severe urinary incontinence, but few receive treatment. A new Funding Opportunity Announcement from AHRQ seeks applications for increasing the dissemination and implementation of patient-centered outcomes research findings in primary care practices to improve nonsurgical treatments for urinary incontinence among adult women. This FOA grew from a PCORI-funded systematic review on Nonsurgical Treatments for Urinary Incontinence among adult women produced by the EPC program in 2018 and a subsequent AHRQ/PCORI stakeholder meeting in June 2019. AHRQ anticipates investing up to $15 million over three years to support up to 5 awards. Grant applicants must propose a comprehensive plan to improve the nonsurgical treatments for urinary incontinence among adult women in ambulatory settings. Projects can build on lessons learned from other AHRQ primary care initiatives and may draw on community-based resources and/or include multilevel implementation strategies aligning improvement strategies between primary care practices and healthcare systems. The application period opened on January 13, 2021 and applications are due March 24, 2021. Potential applicants are encouraged to submit a letter of intent. A technical assistance call on 3:00 pm ET, Thursday, February 25, 2021 will provide a summary of the initiative and address frequently asked questions. Additional information on submitting a letter of intent, registering for the technical assistance call and submitting questions in advance of the call can be found in the FOA. For questions, email UI_grant@ahrq.hhs.gov. https://grants.nih.gov/grants/guide/rfa-files/RFA-HS-21-001.html Progress Report on Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain
(Progress Report, released on January 22, 2021) This is the first progress report for an ongoing living systematic review on plant-based treatments for chronic pain. The systematic review will synthesize evidence on the benefits and harms of plant-based compounds such as cannabinoids and kratom used to treat chronic pain, addressing concerns about severe adverse effects, abuse, misuse, dependence, and addiction. The purpose of this progress report is to describe the body of literature identified thus far. This report will be periodically updated with new studies as they are published and identified, culminating in a systematic review that provides a synthesis of the accumulated evidence. About us: AHRQ's Effective Health Care Program is committed to providing the best available evidence on the outcomes, benefits and harms, and appropriateness of drugs, devices, and health care services and by helping health care professionals, patients, policymakers, and health care systems make informed health care decisions. The program partners with research centers, academic institutions, health professional societies, consumer organizations, and other stakeholders to conduct research, evidence synthesis, evidence translation, dissemination, and implementation of research findings. To learn more: https://effectivehealthcare.ahrq.gov/ Contact us at epc@ahrq.hhs.gov | 
How satisfied are you with this e-mail bulletin? Give Us Your Feedback
No comments:
Post a Comment